NCT01406145View on ClinicalTrials.gov

A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 16, 2011

Primary Completion Date

November 4, 2011

Study Completion Date

November 4, 2011

Conditions
Alzheimer's Disease
Interventions
DRUG

ASP0777

oral tablet

DRUG

Placebo

oral tablet

Trial Locations (2)

33009

MD Clinical, Hallandale

92103

Pacific Research Network, Inc., San Diego

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY